Categories: DrugITNetworksPlatform
TippingPoint Biosciences is developing a new class of therapeutics that can specifically modulate chromatin networks in disease.
Investors 2
Mentions in press and media 3
| Date | Title | Description |
| 01.04.2026 | TippingPoint Biosciences Raises $4.5M in Seed Funding | TippingPoint Biosciences, a San Francisco, CA-based biotechnology company, closed $4.5m in seed financing.
The round was led by SOSV and LKS Fund, with participation from Sazze Partners, Freeflow Ventures, StoryHouse Ventures, Sontag Innova... |
| 04.09.2024 | TippingPoint Biosciences Closes Pre-Seed Funding | TippingPoint Biosciences, a San Francisco, CA-based therapeutic company focused on innovative drug discovery targeting the aberrant DNA in cancer cells, raised a Pre-Seed funding of undisclosed amount.
Backers included Pediatric Brain Tumor... |
| - | TippingPoint Biosciences | “Pioneering new therapies for diseases of chromatin dysfunction. There is a necessity for new types of treatments in diseases like Pediatric Diffuse Midlines Glioma (DMG). Cancer, Chromatin, Health, new solutions.” |
Reviews 0
